The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Poliovirus Vaccine Inactivated Market Research Report 2025
Synopsis
Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
The global Poliovirus Vaccine Inactivated market was valued at US$ 688.5 million in 2023 and is anticipated to reach US$ 926.8 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine Inactivated, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine Inactivated.
Report Scope
The Poliovirus Vaccine Inactivated market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliovirus Vaccine Inactivated market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliovirus Vaccine Inactivated manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Segment by Type
Human Diploid Cell
Monkey Kidney Cell
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliovirus Vaccine Inactivated manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliovirus Vaccine Inactivated in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.
The global Poliovirus Vaccine Inactivated market was valued at US$ 688.5 million in 2023 and is anticipated to reach US$ 926.8 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Poliovirus Vaccine Inactivated, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliovirus Vaccine Inactivated.
Report Scope
The Poliovirus Vaccine Inactivated market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poliovirus Vaccine Inactivated market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliovirus Vaccine Inactivated manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Segment by Type
Human Diploid Cell
Monkey Kidney Cell
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliovirus Vaccine Inactivated manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliovirus Vaccine Inactivated in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Poliovirus Vaccine Inactivated Market Overview
1.1 Product Overview and Scope of Poliovirus Vaccine Inactivated
1.2 Poliovirus Vaccine Inactivated Segment by Type
1.2.1 Global Poliovirus Vaccine Inactivated Market Value Comparison by Type (2024-2030)
1.2.2 Human Diploid Cell
1.2.3 Monkey Kidney Cell
1.3 Poliovirus Vaccine Inactivated Segment by Application
1.3.1 Global Poliovirus Vaccine Inactivated Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Inactivated Market Size Estimates and Forecasts
1.4.1 Global Poliovirus Vaccine Inactivated Revenue 2019-2030
1.4.2 Global Poliovirus Vaccine Inactivated Sales 2019-2030
1.4.3 Global Poliovirus Vaccine Inactivated Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poliovirus Vaccine Inactivated Market Competition by Manufacturers
2.1 Global Poliovirus Vaccine Inactivated Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poliovirus Vaccine Inactivated Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poliovirus Vaccine Inactivated Average Price by Manufacturers (2019-2024)
2.4 Global Poliovirus Vaccine Inactivated Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliovirus Vaccine Inactivated, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliovirus Vaccine Inactivated, Product Type & Application
2.7 Poliovirus Vaccine Inactivated Market Competitive Situation and Trends
2.7.1 Poliovirus Vaccine Inactivated Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poliovirus Vaccine Inactivated Players Market Share by Revenue
2.7.3 Global Poliovirus Vaccine Inactivated Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poliovirus Vaccine Inactivated Retrospective Market Scenario by Region
3.1 Global Poliovirus Vaccine Inactivated Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poliovirus Vaccine Inactivated Global Poliovirus Vaccine Inactivated Sales by Region: 2019-2030
3.2.1 Global Poliovirus Vaccine Inactivated Sales by Region: 2019-2024
3.2.2 Global Poliovirus Vaccine Inactivated Sales by Region: 2025-2030
3.3 Global Poliovirus Vaccine Inactivated Global Poliovirus Vaccine Inactivated Revenue by Region: 2019-2030
3.3.1 Global Poliovirus Vaccine Inactivated Revenue by Region: 2019-2024
3.3.2 Global Poliovirus Vaccine Inactivated Revenue by Region: 2025-2030
3.4 North America Poliovirus Vaccine Inactivated Market Facts & Figures by Country
3.4.1 North America Poliovirus Vaccine Inactivated Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poliovirus Vaccine Inactivated Sales by Country (2019-2030)
3.4.3 North America Poliovirus Vaccine Inactivated Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Poliovirus Vaccine Inactivated Market Facts & Figures by Country
3.5.1 Europe Poliovirus Vaccine Inactivated Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poliovirus Vaccine Inactivated Sales by Country (2019-2030)
3.5.3 Europe Poliovirus Vaccine Inactivated Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliovirus Vaccine Inactivated Market Facts & Figures by Country
3.6.1 Asia Pacific Poliovirus Vaccine Inactivated Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poliovirus Vaccine Inactivated Sales by Country (2019-2030)
3.6.3 Asia Pacific Poliovirus Vaccine Inactivated Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Poliovirus Vaccine Inactivated Market Facts & Figures by Country
3.7.1 Latin America Poliovirus Vaccine Inactivated Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poliovirus Vaccine Inactivated Sales by Country (2019-2030)
3.7.3 Latin America Poliovirus Vaccine Inactivated Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliovirus Vaccine Inactivated Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliovirus Vaccine Inactivated Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poliovirus Vaccine Inactivated Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poliovirus Vaccine Inactivated Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poliovirus Vaccine Inactivated Sales by Type (2019-2030)
4.1.1 Global Poliovirus Vaccine Inactivated Sales by Type (2019-2024)
4.1.2 Global Poliovirus Vaccine Inactivated Sales by Type (2025-2030)
4.1.3 Global Poliovirus Vaccine Inactivated Sales Market Share by Type (2019-2030)
4.2 Global Poliovirus Vaccine Inactivated Revenue by Type (2019-2030)
4.2.1 Global Poliovirus Vaccine Inactivated Revenue by Type (2019-2024)
4.2.2 Global Poliovirus Vaccine Inactivated Revenue by Type (2025-2030)
4.2.3 Global Poliovirus Vaccine Inactivated Revenue Market Share by Type (2019-2030)
4.3 Global Poliovirus Vaccine Inactivated Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poliovirus Vaccine Inactivated Sales by Application (2019-2030)
5.1.1 Global Poliovirus Vaccine Inactivated Sales by Application (2019-2024)
5.1.2 Global Poliovirus Vaccine Inactivated Sales by Application (2025-2030)
5.1.3 Global Poliovirus Vaccine Inactivated Sales Market Share by Application (2019-2030)
5.2 Global Poliovirus Vaccine Inactivated Revenue by Application (2019-2030)
5.2.1 Global Poliovirus Vaccine Inactivated Revenue by Application (2019-2024)
5.2.2 Global Poliovirus Vaccine Inactivated Revenue by Application (2025-2030)
5.2.3 Global Poliovirus Vaccine Inactivated Revenue Market Share by Application (2019-2030)
5.3 Global Poliovirus Vaccine Inactivated Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Poliovirus Vaccine Inactivated Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Poliovirus Vaccine Inactivated Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Serum Institute (Bilthoven Biologicals)
6.3.1 Serum Institute (Bilthoven Biologicals) Corporation Information
6.3.2 Serum Institute (Bilthoven Biologicals) Description and Business Overview
6.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Portfolio
6.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
6.4 IMBCA
6.4.1 IMBCA Corporation Information
6.4.2 IMBCA Description and Business Overview
6.4.3 IMBCA Poliovirus Vaccine Inactivated Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IMBCA Poliovirus Vaccine Inactivated Product Portfolio
6.4.5 IMBCA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliovirus Vaccine Inactivated Industry Chain Analysis
7.2 Poliovirus Vaccine Inactivated Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliovirus Vaccine Inactivated Production Mode & Process
7.4 Poliovirus Vaccine Inactivated Sales and Marketing
7.4.1 Poliovirus Vaccine Inactivated Sales Channels
7.4.2 Poliovirus Vaccine Inactivated Distributors
7.5 Poliovirus Vaccine Inactivated Customers
8 Poliovirus Vaccine Inactivated Market Dynamics
8.1 Poliovirus Vaccine Inactivated Industry Trends
8.2 Poliovirus Vaccine Inactivated Market Drivers
8.3 Poliovirus Vaccine Inactivated Market Challenges
8.4 Poliovirus Vaccine Inactivated Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
